We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Cardiome to trade on NASDAQ NASDAQ: CRME TSX: COM VANCOUVER, June 29 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp ("Cardiome" or the "Company') today announced that it has received notice from...
Cardiome receives FDA approvable letter on oxypurinol for gout TSX: COM VANCOUVER, June 24 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp (TSX: COM) today announced that it has received an...
Cardiome to present at the Needham & Company Third Annual Biotechnology Conference TSX: COM VANCOUVER, June 9 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (COM- TSX) reported today that Bob...
Cardiome presents to FDA Advisory Committee TSX: COM VANCOUVER, May 28 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp (TSX: COM) today announced that it is presenting information to the FDA...
Cardiome to present at UBS Global Specialty Pharmaceuticals Conference TSX: COM VANCOUVER, May 19 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (COM- TSX) reported today that Doug Janzen...
Cardiome reports first quarter results TSX: COM VANCOUVER, May 17 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (COM- TSX) reported today financial results for the first quarter ended March...
Cardiome to webcast Q1 financial results TSX: COM VANCOUVER, May 17 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp (TSX: COM) today announced that it will hold a teleconference and webcast on...
Cardiome's Data Safety Monitoring Board recommends continuation of phase 3 atrial arrhythmia trial TSX: COM VANCOUVER, May 7 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp (TSX: COM) today...
Cardiome to present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference TSX: COM VANCOUVER, April 22 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (COM...
Cardiome to present at BioCentury Future Leaders Conference TSX: COM VANCOUVER, March 30 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (COM- TSX) ("Cardiome" or the "Company") reported today...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0.045 | 0.045 | 0.045 | 0 | 0 | CS |
26 | 0 | 0 | 0.045 | 0.045 | 0.045 | 0 | 0 | CS |
52 | 0 | 0 | 0.045 | 0.045 | 0.045 | 0 | 0 | CS |
156 | 0 | 0 | 0.045 | 0.045 | 0.045 | 0 | 0 | CS |
260 | 0 | 0 | 0.045 | 0.045 | 0.045 | 3000 | 0.045 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions